Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
APG-157 by Aveta Biomics for Anaplastic Astrocytoma: Likelihood of Approval
APG-157 is under clinical development by Aveta Biomics and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase...
APG-157 by Aveta Biomics for Glioblastoma Multiforme (GBM): Likelihood of Approval
APG-157 is under clinical development by Aveta Biomics and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...
APG-157 by Aveta Biomics for Oligodendroglioma: Likelihood of Approval
APG-157 is under clinical development by Aveta Biomics and currently in Phase II for Oligodendroglioma. According to GlobalData, Phase II...
APG-157 by Aveta Biomics for Gliosarcoma: Likelihood of Approval
APG-157 is under clinical development by Aveta Biomics and currently in Phase II for Gliosarcoma. According to GlobalData, Phase II...
APG-157 by Aveta Biomics for High-Grade Glioma: Likelihood of Approval
APG-157 is under clinical development by Aveta Biomics and currently in Phase II for High-Grade Glioma. According to GlobalData, Phase...